Ingredient or product comparison
Does GHK-Cu Help Anti-Aging Research: Study Comparison
Before examining individual study parameters, understand that GHK-Cu research spans multiple model systems and outcome measures, making direct comparisons complex. The table below distills key published investigations into their core findings and methodologica
This source-based comparison does not add ratings or recommend a winner.
- Before examining individual study parameters, understand that GHK-Cu research spans multiple model systems and outcome measures, making direct comparisons complex. The table below distills key published investigations into their core findings and methodological constraints.
- Campbell et al. 2012, J Anti Aging Med
- Human fibroblasts (in vitro)
- Genome-wide gene expression (Affymetrix array)
- 31.2% of human genome affected; DNA repair genes upregulated 1.5–2.8×; inflammatory genes downregulated 50–70%
- Supraphysiological concentrations (10 μM); single 24-hour timepoint; immortalized cell line
- Strongest evidence for gene modulation mechanism but questionable physiological relevance at tested concentrations
- Pickart et al. 2015, Wound Repair Regen
- Rat full-thickness excision model
- Wound closure rate, collagen density
- 50% closure achieved 3.4 days faster; collagen density increased 1.6×; organized fiber architecture vs random in controls
- Topical application only; young healthy animals; no chronic wound model
- Validates wound healing acceleration but doesn't address age-impaired healing or systemic effects
- Arul et al. 2005, J Trauma
- Human dermal equivalent (3D culture)
- MMP-1/TIMP-1 ratio, collagen synthesis
- MMP-1 reduced 70%; TIMP-1 increased 1.6×; net collagen accumulation 2.1× control
- Engineered tissue lacks vascular and immune components; unclear if effects sustained beyond 7 days
- Demonstrates shift in tissue remodeling balance but in simplified model system
- Pollard et al. 1990, J Biol Chem
- Purified lysyl oxidase enzyme
- Enzyme activity assay (collagen crosslinking)
- LOX activity increased 230% with GHK-Cu vs CuSO4 at equivalent copper; dose-dependent effect 0.1–10 μM
- Cell-free enzyme assay; doesn't account for cellular uptake or competing copper-binding proteins
- Proves copper delivery mechanism but isolated from cellular complexity
- The evidence converges on GHK-Cu producing measurable biological effects across multiple tissue types and outcome measures, but no single study bridges the gap from mechanism to clinical aging intervention. Research teams examining the peptide's utility need models that account for age-impaired tissue environments, pharmacokinetic constraints, and sustained multi-month administration.